ToTWajjaAWalesPWet al.Population demographic indicators associated with incidence of pyloric stenosis. Arch Pediatr Adolesc Med2005; 159: 520–520.
3.
SommerfieldTChalmersJYoungsonGet al.The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland. Arch Dis Child2008; 93: 1007–1007.
4.
SivitzABTejaniCCohenSG. Evaluation of hypertrophic pyloric stenosis by pediatric emergency physician sonography. Acad Emerg Med2013; 20: 646–646.
5.
MacdessiJOatesRK. Clinical diagnosis of pyloric stenosis: a declining art. BMJ1993; 306: 553–553.
6.
TheobaldIRohrschneiderWKMeissnerPEet al.[Hypertrophic pyloric stenosis: sonographic monitoring of conservative therapy with intravenous atropine sulfate]. Ultraschall Med2000; 21: 170–170.
7.
SinghUKKumarRPrasadR. Oral atropine sulfate for infantile hypertrophic pyloric stenosis. Indian Pediatr2005; 42: 473–473.
8.
KawaharaHTakamaYYoshidaHet al.Medical treatment of infantile hypertrophic pyloric stenosis: should we always slice the “olive”?J Pediatr Surg2005; 40: 1848–1848.
9.
LukacMAntunovicSSVujovicDet al.Is abandonment of nonoperative management of hypertrophic pyloric stenosis warranted?Eur J Pediatr Surg2013; 23: 80–80.
10.
MercerAEPhillipsR. Question 2: can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy?Arch Dis Child2013; 98: 474–474.
11.
WuSFLinHYHuangFKet al.Efficacy of medical treatment for infantile hypertrophic pyloric stenosis: a meta-analysis. Pediatr Neonatol2016; 57: 515–515.
